Abdo KM and Kari FW (1996). The sensitivity of the NTP bioassay for carcinogen hazard evaluation can be modified by dietary restriction. Exp. Toxicol. Pathol. 48: 129-137.
2.
Ad Hoc Interagency Coordinating Committee on the Validation of Alternative Methods (1977). Validation and Regulatory Acceptance of Toxicological Test Methods. National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
3.
Alden CL, Smith PF, Piper CE, and Brei L. (1996). A critical appraisal of the value of the mouse cancer bioassay in safety assessment. Toxicol. Pathol. 24: 722-725.
4.
Allaben WT, Turturro A., Leakey JE, Seng JE, and Hart RW (1996). FDA Points-to-Consider Documents: The need for dietary control for the reduction of experimental variability within animal assays and the use of dietary restriction to achieve dietary control. Toxicol. Pathol. 24: 776-781.
5.
Ames BN and Gold LS (1990). Chemical carcinogenesis: Too many rodent carcinogens . Proc. Natl. Acad. Sci. USA87: 7772-7776.
6.
Boorman GA and Eustis SL (1986). The Pathology Working Group as a means for assuring pathology quality in toxicological studies. In: Managing Conduct and Data Quality of Toxicology Studies, BK Hoover, JK Baldwin, AF Uelner, CE Whitmire , CL Davies, and DW Bristol (eds). Princeton Scientific Publishing, Princeton, New Jersey, pp. 271-275.
7.
Bristol DW, Wachsman JT, and Greenwell A. (1996). The NIEHS Predictive-Toxicology Evaluation Project . Environ. Health Perspect. Suppl. 104(suppl. 5): 1001-1010.
8.
Bucher JR, Portier CJ, Goodman JI, Faustman EM, and Lucier GW (1996). National Toxicology Program studies: Principles of dose selection and applications to mechanistic risk assessment. Fund. Appl. Toxicol. 31: 1-8.
9.
Commission on Risk Assessment and Risk Management (1996). Risk Assessment and Risk Management in Regulatory Decision-Making . Draft report for public review and comment. Washington, D.C. pp. 23-26.
10.
Crump KS (1994). Limitations of biological models of carcinogenesis for low-dose extrapolation. Risk Anal. 14: 883-886.
11.
Donehower LA , Harvey M., Slagle BL, McArthur MJ, Montgomery CJ, Butel JS, and Bradley A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature356: 215-221.
12.
Enslein K. and Craig PN (1982). Carcinogenesis: A predictive structure-activity model. J. Toxicol. Environ. Health19: 521-530.
13.
Environmental Protection Agency (1996). Proposed guidelines for carcinogen risk assessment: Notice of availability and opportunity to comment on proposed guidelines for carcinogen risk assessment. Fed. Reg. 61: 17959-18011 (April 23).
14.
Gold LS and Slone TH (1993). Prediction of carcinogenicity from 2 vs. 4 sex-species groups in the carcinogenic potency database. J. Toxicol. Environ. Health39: 147-161.
15.
Griesemer RA (1992). Dose selection for animal carcinogenicity studies: A practioners perspective. Chem. Res. Toxicol. 5: 737-741.
16.
Hardisty JF and Boorman GA (1986). National Toxicology Program pathology quality assurance procedures. In: Managing Conduct and Data Quality of Toxicology Studies, BK Hoover, JK Baldwin, AF Uener, CE Whitmire , CL Davies, and DW Bristol (eds). Princeton Scientific Publishing, Princeton, New Jersey , pp. 263-269.
17.
Haseman JK (1992). Value of historical controls in the interpretation of rodent tumor data. Drug Information J. 26: 191-200.
18.
Haseman JK (1995). Data analysis: Statistical analysis and the use of historical control data. Reg. Toxicol. Pharmacol. 21: 52-59.
19.
Haseman JK, Arnold J., and Eustis SL (1990). Tumor incidences in Fischer 344 rats: NTP historical data. In: Pathology of the F344 Rat, GA Boorman, SL Eustis, C Montgomery, and M Elwell (eds). Academic Press, San Diego , pp. 555-564.
20.
Haseman JK, Bourbina J., and Eustis SL (1994). The effect of individual housing and other experimental design factors on tumor incidence in B6C3F, mice. Fund. Appl. Toxicol. 23: 44-52.
21.
Haseman JK and Huff JE (1987). Species correlation in long-term carcinogenicity studies. Cancer Lett. 37: 125-132.
22.
Haseman JK, Huff JE, and Boorman GA (1984). Use of historical control data in carcinogenicity students in rodents. Toxicol. Pathol. 12: 126-135.
23.
Haseman JK, Huff JE, Rao GN, Arnold JE, Boorman GA, and McConnell FE (1985). Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N X C3H/ HeN)F1 (B6C3F,) mice. J. Natl. Cancer Inst. 75: 975-984.
24.
Haseman JK, Huff JE, Rao GN, and Eustis SL (1989). Sources of variability in rodent carcinogenicity studies. Fund. Appl. Toxicol. 12: 793-804.
25.
Haseman JK and Johnson FM (1996). Analysis of NTP rodent bioassay data for anticarcinogenic effects. Mutat. Res. 350: 131-141.
26.
Haseman JK and Lockhart A. (1994). The relationship between use of the maximum tolerated dose and study sensitivity for detecting rodent carcinogenicity. Fund. Appl. Toxicol. 22: 382-391.
27.
Haseman JK and Rao GN (1992). Effects of corn oil, time-related changes, and inter-laboratory variability on tumor occurrence in control Fischer-344 (F-344/N) rats. Toxicol. Pathol. 20: 52-60.
28.
Hileman B. (1993). 'Expert intuition' tops in test of carcinogenicity prediction. Chem. Eng. News, June 21, 1993 , 71: 35-37.
29.
Huff JE (1993). Issues and controversies surrounding qualitative strategies for identifying and forecasting cancer causing agents in the human environment. Pharmacol. Toxicol. 72(suppl. 1): 12-27.
30.
Huff J. (1994). Chemicals causally associated with cancers in humans and in laboratory animals. A perfect concordance. In: Carcinogenesis, MP Waalkes and JM Ward (eds). Raven Press, New York, pp. 25-37.
31.
Huff J. (1995). Mechanisms, chemical carcinogenesis, and risk assessment: Cell proliferation and cancer. Am. J. Indust. Med. 27: 293-300.
32.
Huff J. (1996). Alpha 2 u-globulin nephropathy, posed mechanisms, and white ravens. Environ. Health Perspect. 104: 1264-1267.
33.
Huff J., Haseman J., and Rall D. (1991). Scientific concepts, values, and significance of chemical carcinogenesis studies. In: Annual Review of Pharmacology and Toxicology, AK Cho, TF Blaschke, HH Loh, and JL Way (eds). Annual Reviews , Palo Alto, California, pp. 621-652.
34.
Huff JE, McConnell EE, Haseman JK, Boorman GA, Eustis SL, Schwetz BA, Rao GN, Jameson CW, Hart LG, and Rall DP (1988). Carcinogenesis studies: Results of 398 experiments on 104 chemicals for the U.S. National Toxicology Program. In: Living in a Chemical World-Occupational and Environmental Significance of Industrial Carcinogens , C Maltoni and I Selikoff (eds). Annals of the New York Academy of Sciences534: 1-30.
35.
Karstadt M. and Haseman JK (1997). Effect of discounting certain tumor types/sites on evaluations of carcinogenicity in laboratory animals. Am. J. Indust. Med. 31: 485-494.
36.
Keenan KP (1996). The uncontrolled variable in risk assessment: Ad libitum overfed rodents-Fat, facts and fiction. Toxicol. Pathol. 24: 376-383.
37.
Keenan KP, Laroque P., Ballam GC, Soper KA, Dixit R., Mattson BA, Adams SP, and Coleman JB (1996). The effects of diet, ad libitum overfeeding, and moderate dietary restriction on the rodent bioassay: The uncontrolled variable in safety assessment. Toxicol. Pathol. 24: 757-768.
38.
Keenan KP, Smith PF, Hertzog P., Soper K., Ballam GC, and Clark RL (1994). The effects of overfeeding and dietary restriction on Sprague-Dawley rat survival and early pathology biomarkers of aging. Toxicol. Pathol. 22: 300-315.
39.
Lai DY, Baetcke KP, Vu VT, Cotruvo JA, and Eustis SL (1994). Evaluation of reduced protocols for carcinogenicity testing of chemicals: Report of a joint EPA/NIEHS workshop. Reg. Toxicol. Pharmacol. 19: 183-201.
40.
Maronpot RR and Boorman GA (1996). The contribution of the mouse in hazard identification studies. Toxicol. Pathol . 24: 726-731.
41.
Moolgavkar SH (1994). Biological models of carcinogenesis and quantitative cancer risk assessment. Risk Anal. 14: 879-882.
42.
National Toxicology Program ( 1997). Eighth Biennial Report on Carcinogens. National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.
43.
Rall DP, Hogan MD, Huff JE, Schwetz BA, and Tennant RW (1987). Alternatives to using human experience in assessing health risks. Ann. Rev. Public Health8: 355-385.
44.
Rao GN (1996). New diet (NTP-2000) for rats in the National Toxicology Program toxicity and carcinogenicity studies. Fund. Appl. Toxicol. 32: 102-108.
45.
Rao GN (1995). Husbandry procedures other than dietary restriction for lowering body weight and tumor/disease rates in Fischer 344 rats. In: Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies, RW Hart, DA Neumann, and RT Robertson (eds). International Life Sciences Institute, Washington D.C., pp. 51-62.
46.
Rao GN, Haseman JK, Grumbein S., Crawford DD, and Eustis SL (1990). Growth, body weight, survival, and tumor trends in F-344/N rats during an eleven-year period. Toxicol. Pathol . 18: 61-70.
47.
Richards AM (1994). Application of SAR methods to non-congeneric data bases associated with carcinogenicity and mutagenicity: Issues and approaches . Mutat. Res. 305: 73-97.
48.
Stokes WS (1997). Animal use alternatives in research and testing: Obligations and opportunity. Lab Anim. 26: 28-32.
49.
Tennant R. (1997). Identifying carcinogens-A strategy for use of abbreviated models. Toxicol. Pathol. 25: 240-241.
50.
Tennant RW, French JE, and Spalding JW (1995). Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103: 942-950.
51.
Tennant RW, Spalding J., Stasiewicz S., and Ashby J. (1990). Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program. Mutagenesis5: 3-14.
52.
Thurman JD, Bucci TJ, Hart RW, and Turturro A. (1994). Survival, body weight, and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats. Toxicol. Pathol. 22: 1-9.
53.
Turturro A., Duffy P., and Hart RW (1995). The effect of caloric modulation on toxicity studies . In: Dietary Restriction: Implications for the Design and Interpretation of Toxicity and Carcinogenicity Studies, RW Hart, DA Neumann, and RT Robertson (eds). International Life Sciences Institute , Washington, D.C., pp. 79-98.
54.
Ward JM, Hardisty JF, Hailey JR, and Street CS (1995). Peer review in toxicologic pathology. Toxicol. Pathol. 23: 226-234.